Oral Vaccine Market Size, Share, Growth, and Industry Analysis, By Type (Rotavirus Vaccine, Cholera Vaccine, Oral Polio Vaccine, Others), By Application (Public, Private), Regional Insights and Forecast to 2035

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Oral Vaccine Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Oral Vaccine Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Oral Vaccine Business Mode and Production Process
2.3.1 Oral Vaccine Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Oral Vaccine Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Oral Vaccine
2.4.2 Raw Material Cost of Oral Vaccine
2.4.3 Labor Cost of Oral Vaccine
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global Oral Vaccine Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Oral Vaccine Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Oral Vaccine Price by Manufacturer (2021-2026)
4.4 Oral Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Oral Vaccine, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Oral Vaccine, Product Offered and Application
4.7 Oral Vaccine Market Competitive Situation and Trends
4.7.1 Oral Vaccine Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Oral Vaccine Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Oral Vaccine Market Historical Development by Geographic Region (2021-2026)
5.1 Global Oral Vaccine Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Oral Vaccine Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Oral Vaccine Market Status by Country (2021-2026)
5.3.1 North America Oral Vaccine Sales Volume by Country (2021-2026)
5.3.2 North America Oral Vaccine Revenue by Country (2021-2026)
5.3.3 United States Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Oral Vaccine Market Status by Country (2021-2026)
5.4.1 Europe Oral Vaccine Sales Volume by Country (2021-2026)
5.4.2 Europe Oral Vaccine Revenue by Country (2021-2026)
5.4.3 Germany Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Oral Vaccine Market Status by Country (2021-2026)
5.5.1 Asia Pacific Oral Vaccine Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Oral Vaccine Revenue by Country (2021-2026)
5.5.3 China Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Oral Vaccine Market Status by Country (2021-2026)
5.6.1 Latin America Oral Vaccine Sales Volume by Country (2021-2026)
5.6.2 Latin America Oral Vaccine Revenue by Country (2021-2026)
5.6.3 Mexico Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Oral Vaccine Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Oral Vaccine Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Oral Vaccine Revenue by Country (2021-2026)
5.7.3 GCC Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Oral Vaccine Sales Volume, Revenue and Growth (2021-2026)

6 Global Oral Vaccine Market Historical Development by Product Type (2021-2026)
6.1 Oral Vaccine Definition by Type
6.2 Global Oral Vaccine Historical Sales Volume by Product Type (2021-2026)
6.3 Global Oral Vaccine Historical Revenue by Product Type (2021-2026)
6.4 Global Oral Vaccine Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Oral Vaccine Historical Sales Volume, Revenue and Growth Rate of Rotavirus Vaccine (2021-2026)
6.5.2 Global Oral Vaccine Historical Sales Volume, Revenue and Growth Rate of Cholera Vaccine (2021-2026)
6.5.3 Global Oral Vaccine Historical Sales Volume, Revenue and Growth Rate of Oral Polio Vaccine (2021-2026)
6.5.4 Global Oral Vaccine Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)

7 Global Oral Vaccine Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Oral Vaccine Historical Sales Volume by End User (2021-2026)
7.3 Global Oral Vaccine Historical Revenue by End User (2021-2026)
7.4 Global Oral Vaccine Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Oral Vaccine Historical Sales Volume, Revenue and Growth Rate of Public (2021-2026)
7.5.2 Global Oral Vaccine Historical Sales Volume, Revenue and Growth Rate of Private (2021-2026)

8 Leading Companies Profiles
8.1 Halfkin Bio-Pharmaceuticals
8.1.1 Halfkin Bio-Pharmaceuticals Corporation Information
8.1.2 Halfkin Bio-Pharmaceuticals - Oral Vaccine Product Portfolio and Specification
8.1.3 Halfkin Bio-Pharmaceuticals Performance Analysis (2021-2026)
8.1.4 Halfkin Bio-Pharmaceuticals Business and Markets Served
8.1.5 Halfkin Bio-Pharmaceuticals Recent Developments
8.2 Bio-Med
8.2.1 Bio-Med Corporation Information
8.2.2 Bio-Med - Oral Vaccine Product Portfolio and Specification
8.2.3 Bio-Med Performance Analysis (2021-2026)
8.2.4 Bio-Med Business and Markets Served
8.2.5 Bio-Med Recent Developments
8.3 GSK
8.3.1 GSK Corporation Information
8.3.2 GSK - Oral Vaccine Product Portfolio and Specification
8.3.3 GSK Performance Analysis (2021-2026)
8.3.4 GSK Business and Markets Served
8.3.5 GSK Recent Developments
8.4 Lanzhou Institute
8.4.1 Lanzhou Institute Corporation Information
8.4.2 Lanzhou Institute - Oral Vaccine Product Portfolio and Specification
8.4.3 Lanzhou Institute Performance Analysis (2021-2026)
8.4.4 Lanzhou Institute Business and Markets Served
8.4.5 Lanzhou Institute Recent Developments
8.5 Bibcol
8.5.1 Bibcol Corporation Information
8.5.2 Bibcol - Oral Vaccine Product Portfolio and Specification
8.5.3 Bibcol Performance Analysis (2021-2026)
8.5.4 Bibcol Business and Markets Served
8.5.5 Bibcol Recent Developments
8.6 Valneva
8.6.1 Valneva Corporation Information
8.6.2 Valneva - Oral Vaccine Product Portfolio and Specification
8.6.3 Valneva Performance Analysis (2021-2026)
8.6.4 Valneva Business and Markets Served
8.6.5 Valneva Recent Developments
8.7 Tiantan Biological
8.7.1 Tiantan Biological Corporation Information
8.7.2 Tiantan Biological - Oral Vaccine Product Portfolio and Specification
8.7.3 Tiantan Biological Performance Analysis (2021-2026)
8.7.4 Tiantan Biological Business and Markets Served
8.7.5 Tiantan Biological Recent Developments
8.8 Merck
8.8.1 Merck Corporation Information
8.8.2 Merck - Oral Vaccine Product Portfolio and Specification
8.8.3 Merck Performance Analysis (2021-2026)
8.8.4 Merck Business and Markets Served
8.8.5 Merck Recent Developments
8.9 Shanghai United Cell
8.9.1 Shanghai United Cell Corporation Information
8.9.2 Shanghai United Cell - Oral Vaccine Product Portfolio and Specification
8.9.3 Shanghai United Cell Performance Analysis (2021-2026)
8.9.4 Shanghai United Cell Business and Markets Served
8.9.5 Shanghai United Cell Recent Developments
8.10 Sanofi
8.10.1 Sanofi Corporation Information
8.10.2 Sanofi - Oral Vaccine Product Portfolio and Specification
8.10.3 Sanofi Performance Analysis (2021-2026)
8.10.4 Sanofi Business and Markets Served
8.10.5 Sanofi Recent Developments
8.11 PaxVax
8.11.1 PaxVax Corporation Information
8.11.2 PaxVax - Oral Vaccine Product Portfolio and Specification
8.11.3 PaxVax Performance Analysis (2021-2026)
8.11.4 PaxVax Business and Markets Served
8.11.5 PaxVax Recent Developments
8.12 Serum Institute
8.12.1 Serum Institute Corporation Information
8.12.2 Serum Institute - Oral Vaccine Product Portfolio and Specification
8.12.3 Serum Institute Performance Analysis (2021-2026)
8.12.4 Serum Institute Business and Markets Served
8.12.5 Serum Institute Recent Developments
8.13 Panacea Biotec Ltd
8.13.1 Panacea Biotec Ltd Corporation Information
8.13.2 Panacea Biotec Ltd - Oral Vaccine Product Portfolio and Specification
8.13.3 Panacea Biotec Ltd Performance Analysis (2021-2026)
8.13.4 Panacea Biotec Ltd Business and Markets Served
8.13.5 Panacea Biotec Ltd Recent Developments
8.14 EuBiologics
8.14.1 EuBiologics Corporation Information
8.14.2 EuBiologics - Oral Vaccine Product Portfolio and Specification
8.14.3 EuBiologics Performance Analysis (2021-2026)
8.14.4 EuBiologics Business and Markets Served
8.14.5 EuBiologics Recent Developments
8.15 Vabiotech
8.15.1 Vabiotech Corporation Information
8.15.2 Vabiotech - Oral Vaccine Product Portfolio and Specification
8.15.3 Vabiotech Performance Analysis (2021-2026)
8.15.4 Vabiotech Business and Markets Served
8.15.5 Vabiotech Recent Developments

9 Global Oral Vaccine Market Forecast by Product Type and End User (2026-2034)
9.1 Global Oral Vaccine Market Forecast by Product Type (2026-2034)
9.1.1 Global Oral Vaccine Sales Volume, Revenue Forecast and Growth Rate of Rotavirus Vaccine (2026-2034)
9.1.2 Global Oral Vaccine Sales Volume, Revenue Forecast and Growth Rate of Cholera Vaccine (2026-2034)
9.1.3 Global Oral Vaccine Sales Volume, Revenue Forecast and Growth Rate of Oral Polio Vaccine (2026-2034)
9.1.4 Global Oral Vaccine Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
9.2 Global Oral Vaccine Market Forecast by End User (2026-2034)
9.2.1 Global Oral Vaccine Sales Volume, Revenue Forecast and Growth Rate of Public (2026-2034)
9.2.2 Global Oral Vaccine Sales Volume, Revenue Forecast and Growth Rate of Private (2026-2034)

10 Global Oral Vaccine Market Forecast by Geographic Region (2026-2034)
10.1 Global Oral Vaccine Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Oral Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer